Ratings Hiscox Ltd OTC Markets

Equities

HCXLY

US43358P1021

Market Closed - OTC Markets Other stock markets 07:02:37 24/05/2024 pm IST			5-day change	1st Jan Change
29.27 ^USD	-3.70%		-.--%	+7.41%

08/05	UBS raises Centrica to 'buy' from 'neutral	AN
07/05	AstraZeneca target raised; Antofagasta lowered	AN

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 8.44 and 7.75 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analyst opinion has improved significantly over the past four months.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

Ratings chart - Surperformance

Sector: Property & Casualty Insurance

	1st Jan change	Capi.	ESG Refinitiv
HISCOX LTD	+7.41%	4.98B	-
TOKIO MARINE HOLDINGS, INC.	+55.26%	67.71B	B-
AMERICAN INTERNATIONAL GROUP, INC.	+15.60%	52.31B	C+
THE TRAVELERS COMPANIES	+10.42%	49.39B	B
THE ALLSTATE CORPORATION	+17.25%	44.21B	B-
ARCH CAPITAL GROUP LTD.	+36.93%	38.38B	B-
MS&AD INSURANCE GROUP HOLDINGS, INC.	+78.02%	33.19B	B
INTACT FINANCIAL CORPORATION	+11.44%	29.8B	B-
FAIRFAX FINANCIAL HOLDINGS LIMITED	+25.26%	25.44B	C-
SAMPO OYJ	+0.73%	21.46B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes